
Ocular Therapeutix Inc
NASDAQ:OCUL

Income Statement
Earnings Waterfall
Ocular Therapeutix Inc
Revenue
|
63.7m
USD
|
Cost of Revenue
|
-5.6m
USD
|
Gross Profit
|
58.1m
USD
|
Operating Expenses
|
-229.9m
USD
|
Operating Income
|
-171.8m
USD
|
Other Expenses
|
-21.7m
USD
|
Net Income
|
-193.5m
USD
|
Income Statement
Ocular Therapeutix Inc
Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1
N/A
|
1
+51%
|
2
+31%
|
2
+19%
|
2
-4%
|
2
+2%
|
2
-1%
|
2
+3%
|
2
+4%
|
2
+1%
|
2
N/A
|
2
+2%
|
2
-2%
|
2
-7%
|
2
+12%
|
2
-1%
|
2
+1%
|
2
+8%
|
2
N/A
|
2
+15%
|
4
+71%
|
6
+50%
|
7
+14%
|
12
+69%
|
17
+41%
|
22
+27%
|
32
+46%
|
39
+19%
|
44
+13%
|
49
+13%
|
50
+1%
|
50
0%
|
51
+4%
|
52
+0%
|
55
+6%
|
58
+6%
|
58
+1%
|
60
+2%
|
61
+2%
|
61
+1%
|
64
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
|
Gross Profit |
1
N/A
|
1
+51%
|
1
+29%
|
2
+17%
|
1
-9%
|
1
-1%
|
1
-3%
|
1
+2%
|
1
+2%
|
1
+1%
|
1
-1%
|
1
+2%
|
1
N/A
|
1
-7%
|
2
+13%
|
2
-1%
|
2
+1%
|
2
+7%
|
1
-25%
|
1
-29%
|
2
+118%
|
3
+75%
|
5
+40%
|
10
+116%
|
15
+52%
|
20
+30%
|
29
+46%
|
35
+19%
|
39
+13%
|
45
+14%
|
45
+1%
|
45
+0%
|
47
+4%
|
47
+1%
|
50
+6%
|
53
+6%
|
53
+1%
|
54
+2%
|
55
+2%
|
56
+0%
|
58
+4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(28)
|
(28)
|
(32)
|
(37)
|
(40)
|
(43)
|
(44)
|
(43)
|
(45)
|
(50)
|
(57)
|
(63)
|
(63)
|
(61)
|
(56)
|
(56)
|
(61)
|
(67)
|
(75)
|
(83)
|
(88)
|
(86)
|
(84)
|
(80)
|
(78)
|
(86)
|
(98)
|
(109)
|
(117)
|
(120)
|
(120)
|
(122)
|
(126)
|
(131)
|
(134)
|
(135)
|
(136)
|
(146)
|
(184)
|
(197)
|
(230)
|
|
Selling, General & Administrative |
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
(18)
|
(23)
|
(29)
|
(33)
|
(33)
|
(29)
|
(23)
|
(21)
|
(24)
|
(27)
|
(34)
|
(41)
|
(47)
|
(50)
|
(49)
|
(49)
|
(49)
|
(53)
|
(59)
|
(64)
|
(67)
|
(68)
|
(69)
|
(70)
|
(72)
|
(75)
|
(77)
|
(76)
|
(74)
|
(79)
|
(89)
|
(94)
|
(102)
|
|
Research & Development |
(19)
|
(19)
|
(21)
|
(25)
|
(27)
|
(29)
|
(29)
|
(27)
|
(27)
|
(27)
|
(28)
|
(30)
|
(31)
|
(32)
|
(33)
|
(35)
|
(37)
|
(40)
|
(41)
|
(41)
|
(41)
|
(36)
|
(34)
|
(31)
|
(29)
|
(34)
|
(39)
|
(45)
|
(50)
|
(52)
|
(52)
|
(53)
|
(53)
|
(55)
|
(57)
|
(58)
|
(61)
|
(67)
|
(81)
|
(103)
|
(128)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
0
|
0
|
|
Operating Income |
(27)
N/A
|
(27)
-1%
|
(31)
-13%
|
(35)
-14%
|
(38)
-8%
|
(42)
-9%
|
(43)
-4%
|
(41)
+4%
|
(43)
-5%
|
(48)
-12%
|
(56)
-15%
|
(62)
-11%
|
(62)
0%
|
(60)
+4%
|
(55)
+8%
|
(55)
+1%
|
(59)
-8%
|
(65)
-10%
|
(73)
-12%
|
(82)
-11%
|
(86)
-5%
|
(83)
+4%
|
(79)
+4%
|
(70)
+12%
|
(63)
+10%
|
(66)
-6%
|
(69)
-4%
|
(74)
-8%
|
(78)
-5%
|
(76)
+3%
|
(75)
+0%
|
(77)
-3%
|
(79)
-2%
|
(83)
-6%
|
(84)
-1%
|
(82)
+3%
|
(82)
-1%
|
(91)
-11%
|
(128)
-40%
|
(141)
-10%
|
(172)
-22%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
(1)
|
4
|
(1)
|
(8)
|
(24)
|
(26)
|
(93)
|
(65)
|
(34)
|
(14)
|
71
|
53
|
43
|
18
|
8
|
(5)
|
(7)
|
0
|
(13)
|
(10)
|
(10)
|
(5)
|
6
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
14
|
(14)
|
0
|
(28)
|
(28)
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(29)
N/A
|
(29)
-2%
|
(33)
-12%
|
(37)
-13%
|
(40)
-7%
|
(43)
-8%
|
(44)
-3%
|
(43)
+4%
|
(45)
-5%
|
(50)
-12%
|
(57)
-15%
|
(63)
-10%
|
(63)
0%
|
(61)
+4%
|
(56)
+8%
|
(56)
+1%
|
(60)
-8%
|
(63)
-6%
|
(74)
-17%
|
(78)
-5%
|
(86)
-11%
|
(91)
-5%
|
(103)
-13%
|
(96)
+7%
|
(156)
-62%
|
(131)
+16%
|
(103)
+21%
|
(88)
+14%
|
(7)
+93%
|
(22)
-239%
|
(33)
-46%
|
(59)
-83%
|
(71)
-20%
|
(89)
-25%
|
(91)
-2%
|
(67)
+26%
|
(81)
-20%
|
(115)
-43%
|
(138)
-20%
|
(174)
-26%
|
(194)
-11%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(29)
|
(29)
|
(33)
|
(37)
|
(40)
|
(43)
|
(44)
|
(43)
|
(45)
|
(50)
|
(57)
|
(63)
|
(63)
|
(61)
|
(56)
|
(56)
|
(60)
|
(63)
|
(74)
|
(78)
|
(86)
|
(91)
|
(103)
|
(96)
|
(156)
|
(131)
|
(103)
|
(88)
|
(7)
|
(22)
|
(33)
|
(59)
|
(71)
|
(89)
|
(91)
|
(67)
|
(81)
|
(115)
|
(138)
|
(174)
|
(194)
|
|
Net Income (Common) |
(29)
N/A
|
(29)
-2%
|
(33)
-12%
|
(37)
-13%
|
(40)
-7%
|
(43)
-8%
|
(44)
-3%
|
(43)
+4%
|
(45)
-5%
|
(50)
-12%
|
(57)
-15%
|
(63)
-10%
|
(63)
0%
|
(61)
+4%
|
(56)
+8%
|
(56)
+1%
|
(60)
-8%
|
(63)
-6%
|
(74)
-17%
|
(78)
-5%
|
(86)
-11%
|
(91)
-5%
|
(103)
-13%
|
(96)
+7%
|
(156)
-62%
|
(131)
+16%
|
(103)
+21%
|
(88)
+14%
|
(7)
+93%
|
(22)
-239%
|
(33)
-46%
|
(59)
-83%
|
(71)
-20%
|
(89)
-25%
|
(91)
-2%
|
(67)
+26%
|
(81)
-20%
|
(115)
-43%
|
(138)
-20%
|
(174)
-26%
|
(194)
-11%
|
|
EPS (Diluted) |
-1.34
N/A
|
-1.36
-1%
|
-1.48
-9%
|
-1.49
-1%
|
-1.71
-15%
|
-1.73
-1%
|
-1.8
-4%
|
-1.72
+4%
|
-1.8
-5%
|
-1.8
N/A
|
-1.96
-9%
|
-2.16
-10%
|
-2.2
-2%
|
-1.75
+20%
|
-1.49
+15%
|
-1.42
+5%
|
-1.57
-11%
|
-1.49
+5%
|
-1.72
-15%
|
-1.65
+4%
|
-1.91
-16%
|
-1.74
+9%
|
-1.79
-3%
|
-1.52
+15%
|
-2.56
-68%
|
-1.72
+33%
|
-1.34
+22%
|
-1.03
+23%
|
-0.09
+91%
|
-0.29
-222%
|
-0.42
-45%
|
-0.76
-81%
|
-0.92
-21%
|
-1.14
-24%
|
-1.16
-2%
|
-0.86
+26%
|
-1.01
-17%
|
-0.87
+14%
|
-0.83
+5%
|
-1.04
-25%
|
-1.22
-17%
|